BackgroundCheck.run
Search For

Alfredo P Wong Deceased681 Scott Ave, Gilbert, AZ 85233

Known as:
Alfredo O Wong Angelo R Wong Al Wong Alfred Wong
Related to:
Elisabeth T Braga

Alfredo Wong Phones & Addresses

681 Scott Ave, Gilbert, AZ 85233    480-8136840   

1280 8Th St, San Francisco, CA 94122    415-7536635   

Queen Creek, AZ   

San Tan Valley, AZ   

Aurora, CO   

Chandler, AZ   

Tempe, AZ   

Maricopa, AZ   

1280 8Th Ave, San Francisco, CA 94122    415-7108311   

Social networks

Alfredo P Wong

Linkedin

Work

Company: Sybase, inc. Sep 2000 Position: Sr. sales comp analyst

Emails

a***[email protected]

Industries

Accounting
Get Report
Control this profile

Mentions for Alfredo P Wong

Alfredo Wong resumes & CV records

Resumes

Alfredo Wong Photo 25

Senior Sales Comp Analyst

Location:
San Francisco, CA
Industry:
Accounting
Work:
Sybase, Inc. since Sep 2000
Sr. Sales Comp Analyst

Publications & IP owners

Us Patents

Drug Coating Providing High Drug Loading

US Patent:
8246986, Aug 21, 2012
Filed:
Sep 23, 2004
Appl. No.:
10/950003
Inventors:
Evangeline Cruz - Hayward CA, US
Gregory Ruhlmann - Cupertino CA, US
Brenda Pollock - Cupertino CA, US
Sherry Li - Cupertino CA, US
Carmelita Garcia - Newark CA, US
Alfredo M. Wong - Sunnyvale CA, US
Ryan Bronz - Cupertino CA, US
Tracy Fink - Campbell CA, US
David Edgren - Los Altos CA, US
Assignee:
Alza Corporation - Vacaville CA
International Classification:
A61K 9/24
A61K 9/22
A61K 9/54
US Classification:
424464, 424458, 424468, 424472
Abstract:
Aqueous drug coatings including at least one insoluble drug, wherein the insoluble drug accounts for about 85 wt % to about 97 wt % of the drug coatings are described. Such drug coatings may include only one insoluble drug, two or more insoluble drugs, or one or more insoluble drugs in combination with one or more soluble drugs.

Oros Push-Stick For Controlled Delivery Of Active Agents

US Patent:
2005008, Apr 28, 2005
Filed:
Sep 24, 2004
Appl. No.:
10/949180
Inventors:
Evangeline Cruz - Hayward CA, US
Sherry Li - Cupertino CA, US
Atul Ayer - Palo Alto CA, US
Brenda Pollock - Cupertino CA, US
Gregory Ruhlmann - Cupertino CA, US
Carmelita Garcia - Newark CA, US
Alfredo Wong - Sunnyvale CA, US
Lawrence Hamel - Mountain View CA, US
International Classification:
A61K009/22
A61K009/36
US Classification:
424468000
Abstract:
A sustained release dosage form is provided comprising a pharmaceutically active agent and pharmaceutically acceptable salts thereof and adapted to release as an erodible solid over a prolonged period of time, wherein the dosage form provides burst release of the pharmaceutically active agent without the use of an immediate release drug coating. The dosage form is able to deliver high doses of poorly soluble or slowly dissolving active agents at a controlled rate. Methods of using the dosage forms to treat disease or conditions in human patients are also disclosed.

Controlled Release Formulations Of Opioid And Nonopioid Analgesics

US Patent:
2005015, Jul 21, 2005
Filed:
Sep 24, 2004
Appl. No.:
10/949141
Inventors:
Evangeline Cruz - Hayward CA, US
Atul Ayer - Palo Alto CA, US
Brenda Pollock - Cupertino CA, US
Carmelita Garcia - Newark CA, US
Sherry Li - Cupertino CA, US
Alfredo Wong - Sunnyvale CA, US
Lawrence Hamel - Mountain View CA, US
Cheri Klein - Northbrook IL, US
Yihong Qiu - Vernon Hills IL, US
Ye Huang - Gurnee IL, US
International Classification:
A61K031/485
A61K031/16
A61K009/22
US Classification:
424468000, 514282000, 514629000
Abstract:
Sustained release dosage forms for twice daily oral dosing to a human patient for providing relief from pain are provided. The sustained release dosage form comprises an immediate release component and a sustained release component, wherein the immediate release component and the sustained release component collectively contain a therapeutically effective amount of an opioid analgesic and a therapeutically effective amount of nonopioid analgesic. In a preferred embodiment, the nonopioid analgesic is acetaminophen and the opioid analgesic is hydrocodone and pharmaceutically acceptable salts thereof, and in preferred embodiments, the pharmaceutically acceptable salt is bitartrate. The dosage forms produce plasma profiles in a patient characterized by a Cmax for hydrocodone of between about 0.6 ng/mL/mg to about 1.4 ng/mL/mg and an AUC for hydrocodone of between about 9.1 ng*hr/mL/mg to about 19.9 ng*hr/mL/mg (per mg hydrocodone bitartrate administered) and a Cmax for acetaminophen of between about 2.8 ng/mL/mg and 7.9 ng/mL/mg and an AUC for acetaminophen of between about 28.6 ng*hr/mL/mg and about 59.1 ng*hr/mL/mg (per mg acetaminophen administered) after a single dose.

Controlled Release Formulations Of Opioid And Nonopioid Analgesics

US Patent:
2006025, Nov 9, 2006
Filed:
Jun 30, 2006
Appl. No.:
11/480124
Inventors:
Evangeline Cruz - Hayward CA, US
Atul Ayer - Palo Alto CA, US
Brenda Pollock - Cupertino CA, US
Carmelita Garcia - Newark CA, US
Sherry Li - Cupertino CA, US
Alfredo Wong - Sunnyvale CA, US
Lawrence Hamel - Mountain View CA, US
Cheri Klein - Northbrook IL, US
Yihong Qiu - Vernon Hills IL, US
Ye Huang - Gurnee IL, US
International Classification:
A61K 31/485
A61K 9/22
A61K 31/16
US Classification:
424468000, 514282000, 514625000
Abstract:
Sustained release dosage forms for twice daily oral dosing to a human patient for providing relief from pain are provided. The sustained release dosage form comprises an immediate release component and a sustained release component, wherein the immediate release component and the sustained release component collectively contain a therapeutically effective amount of an opioid analgesic and a therapeutically effective amount of nonopioid analgesic. In a preferred embodiment, the nonopioid analgesic is acetaminophen and the opioid analgesic is hydrocodone and pharmaceutically acceptable salts thereof, and in preferred embodiments, the pharmaceutically acceptable salt is bitartrate. The dosage forms produce plasma profiles in a patient characterized by a Cmax for hydrocodone of between about 0.6 ng/mL/mg to about 1.4 ng/mL/mg and an AUC for hydrocodone of between about 9.1 ng*hr/mL/mg to about 19.9 ng*hr/mL/mg (per mg hydrocodone bitartrate administered) and a Cmax for acetaminophen of between about 2.8 ng/mL/mg and 7.9 ng/mL/mg and an AUC for acetaminophen of between about 28.6 ng*hr/mL/mg and about 59.1 ng*hr/mL/mg (per mg acetaminophen administered) after a single dose.

Oros Push-Stick For Controlled Delivery Of Active Agents

US Patent:
2010019, Aug 5, 2010
Filed:
Jan 6, 2010
Appl. No.:
12/683283
Inventors:
Evangeline Cruz - Hayward CA, US
Sherry Li - Cupertino CA, US
Atul D. Ayer - Palo Alto CA, US
Brenda J. Pollock - Cupertino CA, US
Gregory C. Ruhlmann - Cupertino CA, US
Carmelita Garcia - Newark CA, US
Alfredo M. Wong - Sunnyvale CA, US
Lawrence G. Hamel - Mountain View CA, US
International Classification:
A61K 9/00
A61K 31/192
A61K 31/4355
A61K 31/165
US Classification:
424400, 514570, 514282, 514629
Abstract:
A sustained release dosage form is provided comprising a pharmaceutically active agent and pharmaceutically acceptable salts thereof and adapted to release as an erodible solid over a prolonged period of time, wherein the dosage form provides burst release of the pharmaceutically active agent without the use of an immediate release drug coating. The dosage form is able to deliver high doses of poorly soluble or slowly dissolving active agents at a controlled rate. Methods of using the dosage forms to treat disease or conditions in human patients are also disclosed.

Controlled Release Formulations Of Opioid And Nonopioid Analgesics

US Patent:
2010022, Sep 2, 2010
Filed:
Mar 2, 2010
Appl. No.:
12/716086
Inventors:
Evangeline Cruz - Hayward CA, US
Atul D. Ayer - Palo Alto CA, US
Brenda J. Pollock - Cupertino CA, US
Carmelita Garcia - Newark CA, US
Sherry Li - Cupertino CA, US
Alfredo M. Wong - Sunnyvale CA, US
Lawrence G. Hamel - Mountain View CA, US
Cheri Enders Klein - Northbrook IL, US
Yihong Qiu - Vernon Hills IL, US
Ye Huang - Gurnee IL, US
International Classification:
A61K 31/485
A61K 9/00
A61P 25/00
US Classification:
424400, 514282
Abstract:
Sustained release dosage forms for twice daily oral dosing to a human patient for providing relief from pain are provided. The sustained release dosage form comprises an immediate release component and a sustained release component, wherein the immediate release component and the sustained release component collectively contain a therapeutically effective amount of an opioid analgesic and a therapeutically effective amount of nonopioid analgesic. In a preferred embodiment, the nonopioid analgesic is acetaminophen and the opioid analgesic is hydrocodone and pharmaceutically acceptable salts thereof, and in preferred embodiments, the pharmaceutically acceptable salt is bitartrate. The dosage forms produce plasma profiles in a patient characterized by a Cmax for hydrocodone of between about 0.6 ng/mL/mg to about 1.4 ng/mL/mg and an AUC for hydrocodone of between about 9.1 ng*hr/mL/mg to about 19.9 ng*hr/mL/mg (per mg hydrocodone bitartrate administered) and a Cmax for acetaminophen of between about 2.8 ng/mL/mg and 7.9 ng/mL/mg and an AUC for acetaminophen of between about 28.6 ng*hr/mL/mg and about 59.1 ng*hr/mL/mg (per mg acetaminophen administered) after a single dose.

Drug Coating Providing High Drug Loading And Methods For Providing The Same

US Patent:
2011031, Dec 29, 2011
Filed:
Apr 11, 2011
Appl. No.:
13/084462
Inventors:
Evangeline Cruz - Hayward CA, US
Gregory Ruhlmann - Cupertino CA, US
Brenda Pollock - Cupertino CA, US
Sherry Li - Cupertino CA, US
Carmelita Garcia - Newark CA, US
Alfredo M. Wong - Sunnyvale CA, US
Ryan Bronz - Cupertino CA, US
Tracy Fink - Campbell CA, US
David Edgren - Los Altos CA, US
International Classification:
A61K 9/00
A61P 25/04
A61P 29/00
A61K 31/167
A61K 31/485
US Classification:
424400, 514629, 514282
Abstract:
The present invention is directed to aqueous drug coatings that include at least one insoluble drug, wherein the drug accounts for about 85 wt % to about 97 wt % of the drug coatings. A drug coating according to the present invention may include only one insoluble drug, two or more insoluble drugs, or one or more insoluble drugs in combination with one or more soluble drugs. The present invention also includes drug coating formulations suitable for providing drug coatings according to the present invention and dosage forms that include a drug coating according to the present invention.

Controlled Release Formulations Of Opioid And Nonopioid Analgesics

US Patent:
2012016, Jun 28, 2012
Filed:
Nov 18, 2011
Appl. No.:
13/300380
Inventors:
Evangeline Cruz - Hayward CA, US
Atul D. Ayer - Palo Alto CA, US
Brenda J. Pollock - Cupertino CA, US
Carmelita Garcia - Newark CA, US
Sherry Li - Cupertino CA, US
Alfredo M. Wong - Sunnyvale CA, US
Lawrence G. Hamel - Mountain View CA, US
Cheri Enders Klein - Northbrook IL, US
Yihong Qiu - Vernon Hills IL, US
Ye Huang - Gurnee IL, US
International Classification:
A61K 31/485
A61P 25/04
A61P 29/00
US Classification:
514282
Abstract:
Sustained release dosage forms for twice daily oral dosing to a human patient for providing relief from pain are provided. The sustained release dosage form comprises an immediate release component and a sustained release component, wherein the immediate release component and the sustained release component collectively contain a therapeutically effective amount of an opioid analgesic and a therapeutically effective amount of nonopioid analgesic. In a preferred embodiment, the nonopioid analgesic is acetaminophen and the opioid analgesic is hydrocodone and pharmaceutically acceptable salts thereof, and in preferred embodiments, the pharmaceutically acceptable salt is bitartrate. The dosage forms produce plasma profiles in a patient characterized by a Cmax for hydrocodone of between about 0.6 ng/mL/mg to about 1.4 ng/mL/mg and an AUC for hydrocodone of between about 9.1 ng*hr/mL/mg to about 19.9 ng*hr/mL/mg (per mg hydrocodone bitartrate administered) and a Cmax for acetaminophen of between about 2.8 ng/mL/mg and 7.9 ng/mL/mg and an AUC for acetaminophen of between about 28.6 ng*hr/mL/mg and about 59.1 ng*hr/mL/mg (per mg acetaminophen administered) after a single dose.

Possible Relatives

Cynthia W Wong  David K Wong  Cyrus L Wong  Davin R Wong  Davina H Wong  Dawson J Wong  Dean Wong  Alfredo I Juarez  Alfredo D Julian  Alfredo King 

NOTICE: You may not use BackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. BackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.